Related Experiment Video
Updated: Aug 8, 2026

12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Is there an ideal animal model for SARS?
Kanta Subbarao1, Anjeanette Roberts
1Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 50 South Drive, MSC 8007, Bethesda, MD 20892, USA. ksubbarao@niaid.nih.gov
Trends in Microbiology
|June 9, 2006
Summary
The 2003 severe acute respiratory syndrome (SARS) outbreak was managed without specific treatments. Animal models are crucial for developing SARS vaccines and therapies, but ideal models require consistent, reproducible results.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- The 2003 severe acute respiratory syndrome (SARS) outbreak highlighted the need for effective interventions.
- Public health measures controlled the SARS outbreak before specific antiviral drugs, vaccines, or immunotherapies were available.
- Since the outbreak, various animal models have been developed to study SARS pathogenesis and evaluate potential treatments.
Purpose of the Study:
- To define the characteristics of an ideal animal model for SARS research.
- To assess the strengths and limitations of existing animal models for SARS pathogenesis and vaccine development.
Main Methods:
- Review and critical analysis of existing literature on SARS animal models.
- Evaluation of consistency and reproducibility of findings across different models.
- Identification of key criteria for an ideal SARS research model.
Main Results:
- No current animal model perfectly replicates human SARS.
- Existing models have contributed to understanding SARS pathogenesis and principles for vaccine and immunotherapy development.
- Demonstrating consistency and reproducibility is essential for validating a model's utility.
Conclusions:
- An ideal animal model for SARS research should exhibit consistent and reproducible characteristics.
- Further refinement of animal models is necessary for effective SARS vaccine and immunotherapy development.
- Continued evaluation of model strengths and limitations is crucial for advancing SARS research.
More Related Videos
Related Concept Videos
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...

